Core Insights - Eye health is a crucial component of national health, affecting all age groups and significantly impacting quality of life and social burdens [1] - The "14th Five-Year Plan" emphasizes the prevention and treatment of myopia and cataracts, aiming for comprehensive coverage of cataract surgery capabilities by the end of 2027 [1] - The demand for eye health services is shifting from treatment to prevention and improved service quality, driven by economic development and an aging population [1] Group 1: Policy and Planning - The National Health Commission has identified eye diseases, particularly retinal diseases, as key areas for prevention and management, focusing on early screening and long-term care for the elderly [2] - The burden of neovascular age-related macular degeneration (nAMD) is expected to rise significantly, with the number of patients projected to increase from 4.5 million in 2020 to 8.8 million by 2050 [2] - If not addressed, approximately 75.7% of nAMD patients may progress to legal blindness within three years, highlighting the urgent need for effective interventions [2] Group 2: Innovation in Treatment - Bayer's Eylea 8mg has been launched nationwide, offering a more effective treatment option for nAMD patients with longer intervals between injections, potentially improving treatment adherence and quality of life [2][3] - Clinical trials have shown that Eylea 8mg can achieve similar vision improvement with fewer injections compared to the 2mg dosage, thus reducing the treatment burden on patients [3] - The drug's ability to decrease injection frequency addresses both patient and healthcare provider concerns, facilitating better long-term management of nAMD [3] Group 3: Comprehensive Eye Health Solutions - A comprehensive visual health protection system is essential for safeguarding national eye health, with initiatives targeting all demographics and life stages [5] - EssilorLuxottica has introduced new products for myopia management and adult visual health, alongside collaborations to enhance consumer insights and industry standards [5] - The "National Visual Health Report (2026 Edition)" is being developed to further address myopia prevention and expand into comprehensive eye health strategies [5] Group 4: Cross-Industry Innovations - EssilorLuxottica is also venturing into hearing health, addressing the significant market gap for hearing aids, with an estimated 1.25 billion people globally suffering from mild to moderate hearing loss [6] - The Nuance Audio hearing glasses, which integrate advanced hearing technology into stylish eyewear, have been launched to cater to individuals with hearing impairments [6][7] - Following FDA and CE certifications, the Nuance Audio product is set for accelerated introduction into global markets, including China, to benefit a larger user base [7]

Core Insights - The eighth China International Import Expo (CIIE) is being held from November 5 to 10, marking the 30th anniversary of China's opening up, with EssilorLuxottica participating as a consistent exhibitor for eight years [1] - EssilorLuxottica is showcasing new products in areas such as myopia management for children and adolescents, adult vision health, and wearable devices, while also collaborating with ecosystem partners on consumer insights, industry standards, and public education [1] - The company aims to leverage innovation to reshape consumer experiences in vision care, focusing on classic brands, medical technology, and wearable devices [1] Company Initiatives - EssilorLuxottica is launching the Star Control 2.0 lenses, which feature enhanced optical technology to significantly improve the effectiveness of myopia prevention compared to previous versions [2] - The company is also releasing a digital version of "Our Eyes," a 3D book that has been well-received since its 2020 launch, aimed at educating children and adolescents about eye health through engaging multimedia content [2] - The new "National Vision Health Report (2026 Edition)" is being developed to address myopia prevention and expand to a "lifecycle eye health" approach, utilizing successful experiences from the myopia prevention field [1][2]

Core Insights - EssilorLuxottica celebrates its 30th anniversary in China and showcases multiple new products at the China International Import Expo, focusing on myopia management for children and adolescents, adult vision health, and wearable devices [1] - The company collaborates with partners to launch initiatives in consumer insights, industry standards, and public welfare education [1] - The 2026 edition of the National Vision Health Report is initiated, aiming to deepen discussions on myopia prevention and expand to "lifecycle eye health" [1] Group 1 - EssilorLuxottica supports the Shanghai Eye Disease Prevention Center in launching the national health industry standard "Guidelines for Graded and Classified Prevention and Treatment of Myopia in Children and Adolescents" [2] - The company provided over 8,000 lenses for a school-based myopia intervention project, which is part of Shanghai's public health system enhancement plan [2] - The new guidelines will promote a graded and classified approach to myopia management, emphasizing early intervention [2] Group 2 - EssilorLuxottica releases a digital version of "Our Eyes," developed in collaboration with leading optometry experts, to meet the educational needs of the digital age [3] - The digital version incorporates the latest knowledge from the "Myopia Prevention and Control White Paper (2025)" and uses animated videos and educational materials to raise awareness among children and adolescents [3] - The company also showcases the innovative Essilor Star Control smart glasses, which feature a monitoring module to help children meet recommended wearing times for effective myopia management [3]